The New England journal of medicine
-
Randomized Controlled Trial Multicenter Study
A Randomized Trial of Intrapartum Fetal ECG ST-Segment Analysis.
Intrapartum fetal ECG monitoring and ST-segment analysis does not lead to better fetal or delivery outcomes compared with standard FHR and CTG monitoring.
pearl -
Randomized Controlled Trial Multicenter Study
Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma.
Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7), showed activity in combination with lenalidomide and dexamethasone in a phase 1b-2 study in patients with relapsed or refractory multiple myeloma. ⋯ Patients with relapsed or refractory multiple myeloma who received a combination of elotuzumab, lenalidomide, and dexamethasone had a significant relative reduction of 30% in the risk of disease progression or death. (Funded by Bristol-Myers Squibb and AbbVie Biotherapeutics; ELOQUENT-2 ClinicalTrials.gov number, NCT01239797.).